Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
The Mantel-Cox Log-Rank Test01:19

The Mantel-Cox Log-Rank Test

The Mantel-Cox log-rank test is a widely used statistical method for comparing the survival distributions of two groups. It tests whether a statistically significant difference exists in survival times between the groups without assuming a specific distribution for the survival data, making it a non-parametric test. This flexibility makes the log-rank test particularly valuable in medical research and other fields where the timing of an event, such as death or disease recurrence, is of interest.
Pulmonary Function Tests01:25

Pulmonary Function Tests

Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Linking Exosomal MicroRNA Signatures in Sputum and Peripheral Blood to Inflammatory Endotypes in Severe Asthma.

Allergy·2025
Same author

Effect of positive pressure ventilation and bariatric surgery on extracellular vesicle microRNAs in patients with severe obesity and obstructive sleep apnea.

International journal of obesity (2005)·2022
Same author

Removal efficiency for emerging contaminants in a WWTP from Madrid (Spain) after secondary and tertiary treatment and environmental impact on the Manzanares River.

The Science of the total environment·2021
Same author

The GOLD Summit on chronic obstructive pulmonary disease in low- and middle-income countries.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2019
Same author

Bootstrap parametric GB2 and bootstrap nonparametric distributions for studying shiga toxin-producing Escherichia coli strains growth rate variability.

Food research international (Ottawa, Ont.)·2019
Same author

Bayesian modeling of two- and three-species bacterial competition in milk.

Food research international (Ottawa, Ont.)·2018
Same journal

Beyond the 5th percentile: rethinking diagnostic thresholds in pulmonary function testing.

The European respiratory journal·2026
Same journal

A Transcriptomic Atlas of Chronic Lung Allograft Dysfunction.

The European respiratory journal·2026
Same journal

Risk of cancer and mortality in patients with interstitial lung diseases: Danish cohort study.

The European respiratory journal·2026
Same journal

Proposing a minimal important difference in NTproBNP in pulmonary arterial hypertension.

The European respiratory journal·2026
Same journal

Unlocking growth potential: Ivacaftor therapy and developmental gains in lung and height in a cohort study of children and young adults with cystic fibrosis.

The European respiratory journal·2026
Same journal

Decoding the Lymphangioleiomyomatosis (LAM) Niche Microenvironment <i>via</i> Integrative Analysis of Single Cell Multiomics and Spatial Transcriptomics.

The European respiratory journal·2026
See all related articles

Related Experiment Videos

The modified BODE index: validation with mortality in COPD.

C G Cote1, V M Pinto-Plata, J M Marin

  • 1Pulmonary and Critical Care Medicine, Bay Pines Veterans Administration Health Care System, 10, 000 Bay Pines Boulevard, Bay Pines, FL 33744, USA. claudia.cote@med.va.gov

The European Respiratory Journal
|June 27, 2008
PubMed
Summary
This summary is machine-generated.

The conventional BODE index, using the 6-minute walk distance, effectively predicts mortality in chronic obstructive pulmonary disease (COPD) patients, similar to a modified index utilizing peak oxygen uptake. This supports using the simpler BODE index for COPD evaluation.

Related Experiment Videos

Area of Science:

  • Pulmonary Medicine
  • Cardiopulmonary Exercise Testing
  • Clinical Epidemiology

Background:

  • Peak oxygen uptake (V'(O2)) is a key measure of exercise capacity and survival.
  • The BODE index (Body Mass Index, Obstruction, Dyspnea, Exercise Capacity) is used to assess COPD prognosis.
  • A modified BODE index (mBODE%) using V'(O2) has been proposed, showing correlation with the conventional BODE index.

Purpose of the Study:

  • To compare the predictive ability of the conventional BODE index and the mBODE% for mortality in COPD patients.
  • To evaluate the prognostic value of these indices in a cohort of 444 COPD patients.
  • To determine which index, BODE or mBODE%, is more effective in predicting survival in COPD.

Main Methods:

  • Prospective study of 444 COPD patients followed for a mean of 71 months.
  • Data collected included anthropometrics, spirometry, lung volumes, comorbidities, cardiopulmonary cyclo-ergometry, and 6-minute walk distance (6MWD).
  • Logistic regression analysis was used to identify variables associated with COPD survival.

Main Results:

  • Both the conventional BODE index and the mBODE% were significantly correlated with mortality.
  • Logistic regression identified the BODE index, Charlson's comorbidity index, and exercise capacity (in Watts) as significant predictors of COPD survival.
  • The conventional BODE index demonstrated comparable mortality prediction to the mBODE%.

Conclusions:

  • The conventional BODE index, incorporating the 6-minute walk distance, is as effective as the modified index using peak oxygen uptake in predicting mortality in COPD.
  • These findings support the use of the simpler, conventional BODE index in the comprehensive assessment of COPD patients.
  • The 6-minute walk distance remains a valuable component in prognosticating COPD outcomes.